Explore our premium active pharmaceutical ingredients, synthesized under stringent cGMP and ISO quality assurance frameworks.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
An overall factory construction area of 250,000 square meters under international standard allows us to offer flexible, scalable and cost-effective solutions. Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
Strategic transformation in steroidal hormone active pharmaceutical ingredient (API) production, biotechnology integration, and sustainable chemical sourcing.
Historically, global steroidal API synthesis relied on total chemical synthesis or extraction of diosgenin from wild wild yam tubers. Over the past decade, the global steroids manufacturing industry—spearheaded by advanced Chinese chemical complexes—has experienced a structural paradigm shift toward phytosterol fermentation. By utilizing abundant plant-derived sterols (such as soybean phytosterols) as raw materials, modern factories deploy bio-transformation via Mycobacterium strains to generate core steroidal nucleus precursors: Androst-4-ene-3,17-dione (4-AD), Androsta-1,4-diene-3,17-dione (ADD), and Dehydroepiandrosterone (DHEA).
This biotechnological evolution significantly curtails carbon emissions, reduces reliance on volatile agricultural crops, and ensures stable, high-yield molecular structures for downstream conversion into corticosteroids, sex hormones, progestins, and selective androgen receptor modulators (SARMs).
Information Gain Insight: The transition to phytosterol biotransformation has reduced raw material cost volatility by over 40% globally, allowing China steroid factories to maintain long-term price stability while improving stereospecific purity to exceeding 99.0% prior to final crystallization.
Global regulatory bodies, including the US FDA, European Medicines Agency (EMA), and NMPA, have intensified scrutiny on steroidal impurities, mutagenic intermediates, and residual solvents. Modern pharmaceutical companies purchasing steroid APIs demand full alignment with ICH Q3A/B guidelines for impurities and ICH Q3C guidelines for residual solvents. Advanced Chinese manufacturing sites now incorporate real-time High-Performance Liquid Chromatography coupled with Mass Spectrometry (HPLC-MS) alongside Nuclear Magnetic Resonance (NMR) spectroscopy to ensure zero undetectable isomeric contaminants.
Continuous flow microfluidic reactors replace traditional batch reactors, enabling precise temperature control, mitigating runaway exothermic risks during nitration or oxidation steps, and yielding pristine crystalline structures.
Leading Chinese facilities actively submit Drug Master Files (DMF) to US FDA and obtain Certificates of Suitability (CEP) from EDQM, streamlining registration pathways for international drug manufacturers.
Implementation of enzymatic transformations and closed-loop solvent recycling units dramatically minimizes hazardous waste production, ensuring continuous factory operation under strict environmental protection laws.
Mitigating geopolitical, technical, and regulatory risks through transparent sourcing and customized contract manufacturing.
Global pharmaceutical companies sourcing steroid raw materials and custom peptides face multifaceted procurement hurdles: regulatory non-compliance, batch-to-batch inconsistency, customs bottlenecks, and supply chain fragility. Gentolex Group addresses these complexities by establishing integrated enterprise procurement and custom synthesis pathways.
From initial benchtop R&D (gram scale) to commercial industrial output (multi-ton scale), our chemical engineering team provides tailormade synthesis routes for novel steroid derivatives and custom peptide sequences.
We assist finished dosage form (FDF) manufacturers by providing license-out options, technical documentation dossier packages (CTD format), and direct line-setup support to streamline commercial manufacturing scale-up.
With operational representative hubs in Mexico and South Africa, Gentolex bridges timezone, language, and regulatory barriers, facilitating seamless door-to-door logistics and rapid sample dispatch.
Uncompromising compliance with international pharmacopeia standards (USP, EP, JP, ChP).
Quality reliability is the bedrock of pharmaceutical steroid production. Each batch manufactured in our 250,000 m² industrial facility undergoes comprehensive analytical testing before release. Below is our standard quality verification matrix for steroidal raw materials and therapeutic peptides:
Stay informed with current advances in peptide chemistry, active pharmaceutical ingredient synthesis, and neuroactive compound developments.
Introduction to Selank Acetate API: Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of Thr-Lys-Pro-Arg-Pro-Gly-Pro sequence...
Read Publication →
Trusted Thymosin Beta-4 API Manufacturer and Global Peptide Supplier: As a professional Thymosin Beta-4 API manufacturer, we provide high-purity Tβ4 peptide solutions...
Read Publication →
BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair...
Read Publication →
With continuous development of neuroscience, peptide technology, and life science research, neuroactive peptides have become an important area of investigation...
Read Publication →
SS-31 API, also known as Elamipretide, MTP-131, Bendavia, is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner membrane...
Read Publication →Comprehensive answers regarding bulk steroid synthesis, regulatory documentation, logistics, and quality assurance.
Every commercial batch supplied by Gentolex is shipped with a comprehensive Analytical Package, including the Certificate of Analysis (CoA), HPLC Chromatograms, Mass Spectrometry (MS) spectra, Nuclear Magnetic Resonance (NMR) confirmation, and SDS (Safety Data Sheets). For pharmaceutical buyers, full DMF support and Open Part CTD dossiers can be provided under non-disclosure agreements.
Phytosterol biotransformation utilizes microbial fermentation to selectively cleave the side chains of plant sterols (such as soybean sterols), producing clean steroid precursors like 4-AD and ADD. This biological route yields significantly higher optical purity, reduces toxic heavy metal catalysts, and minimizes isomeric impurities compared to traditional multi-step chemical degradation routes.
We support scalable procurement stages: R&D trial quantities start from 10 grams to 1 kilogram for specialized custom peptides and steroidal reference standards. Commercial production lines support multi-kilogram up to multi-ton bulk batches according to buyer forecasts and production schedules.
Gentolex operates dedicated international supply chain protocols, leveraging regional hubs in Mexico and South Africa alongside established global logistics partners. All products are packaged in compliant, temperature-monitored, discreet chemical containers designed to clear customs smoothly under proper HS code classifications.
High-purity peptide raw materials, targeted metabolic regulators, and specialty industrial compounds.
